Doravirine Clinical Trials
3 recruitingDrug
Phase 21Phase 41Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 2
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800
Recruiting
Phase 4
Doravirine Dose Optimisation in Pregnancy
HIV
University of Liverpool76 enrolled1 locationNCT05630638
Recruiting
Phase 3
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
HIV-1-infection
Chelsea and Westminster NHS Foundation Trust150 enrolled3 locationsNCT04892654